ATH 11.1% 0.4¢ alterity therapeutics limited

Focus on the 83% who wanted to keep taking PBT2 in the imagine...

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    Focus on the 83% who wanted to keep taking PBT2 in the imagine trial

    The data is important but the narrative about lives changed is equally valid

    The mice benefited from PBT2 in a very short time frame (12 days) no reason to believe people won't as well our 6 month trial turned into a 12 month extension study because clinicians, patients and partners recognised the benefits warranted further study

    Metals are now implicated in AD PD and HD we know PBT2 works in the neurones as a chaperone and restores homeostasis it obviously helped most AD patients in the imagine trial and so far is safe

    Even 10% of the market will turn PBT into a billion dollar company

    We got ahead of ourselves and are disappointed because we stopped our upward ascent but we will still be ahead of where we were a month ago

    About 20m plus PBT shares were bought last night at about 4 times the price of 6 months ago some people obviously believe in PBT2

    Hopefully data at 9am monday


    http://pranabio.com/news/pranas-pbt2-reverses-memory-loss-in-normal-aging#.Uv7jtXlR5MM

    GLTA
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $14.55K 3.241M

Buyers (Bids)

No. Vol. Price($)
62 71906262 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 32338803 25
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.